Report Detail

Request for Sample of this report

Pharma & Healthcare Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Biosimilar Market 2018, Forecast to 2023

  • RnM2733517
    • |
  • 07 January, 2019
    • |
  • Global
    • |
  • 135 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

A product is termed as biosimilar product, if it is a biological product with similar characteristics as that of a reference biological product, which possesses approval from agencies such as FDA. There would not be any major clinical difference in effectiveness and safety as that of reference product. Biosimilar products are made of complex molecules with high molecular weight produced through genetic engineering in living cells. Biologics drugs are costlier than respective chemical drugs. Biosimilar drugs can save around 30 to 40 % in terms of price relative to the respective biologics drugs. Biosimilars are useful for the treatment of illnesses such as anemia, autoimmune diseases, cancer, diabetes, growth hormone deficiencies, hematological diseases, kidney failure, rheumatoid arthritis and others. For the manufacturing of biosimilars, manufacturers have to develop environments that are ideal for the living cells, which remain sensitive to environmental conditions. Moreover, they need to develop distinctive process to entice the living cells for producing similar outcome to a prevalent biological treatment. The substitution of biological drugs with biosimilar drugs can save lot of money for public health care sector and patients. The regulatory authorities in developed nations are promoting biosimilar products.

Scope of the Report:
This report focuses on the Biosimilar in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Biosimilar is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Allergan plc
BIOCAD
Biocon
BioXpress Therapeutics SA
Boehringer Ingelheim GmbH
Celltrion Inc.
Coherus BioSciences, Inc
Dr. Reddy’s Laboratories Ltd.
Genor BioPharma Co. Ltd
Intas Pharmaceuticals Limited
Novartis AG
Pfizer, Inc.
Reliance Life Sciences

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Human Growth Hormones
Monoclonal Antibodies
Insulin
Peptides
Erythropoietin
Others

Market Segment by Applications, can be divided into
Oncology
Chronic and Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Others

There are 15 Chapters to deeply display the global Biosimilar market.
Chapter 1, to describe Biosimilar Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Biosimilar, with sales, revenue, and price of Biosimilar, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Biosimilar, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Biosimilar market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Biosimilar sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


Table of Contents

    1 Market Overview

    • 1.1 Biosimilar Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Human Growth Hormones
      • 1.2.2 Monoclonal Antibodies
      • 1.2.3 Insulin
      • 1.2.4 Peptides
      • 1.2.5 Erythropoietin
      • 1.2.6 Others
    • 1.3 Market Analysis by Applications
      • 1.3.1 Oncology
      • 1.3.2 Chronic and Autoimmune Diseases
      • 1.3.3 Growth Hormone Deficiency
      • 1.3.4 Infectious Diseases
      • 1.3.5 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2013-2023)
        • 1.4.1.2 Canada Market States and Outlook (2013-2023)
        • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2013-2023)
        • 1.4.2.2 France Market States and Outlook (2013-2023)
        • 1.4.2.3 UK Market States and Outlook (2013-2023)
        • 1.4.2.4 Russia Market States and Outlook (2013-2023)
        • 1.4.2.5 Italy Market States and Outlook (2013-2023)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2013-2023)
        • 1.4.3.2 Japan Market States and Outlook (2013-2023)
        • 1.4.3.3 Korea Market States and Outlook (2013-2023)
        • 1.4.3.4 India Market States and Outlook (2013-2023)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
        • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
        • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
        • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Allergan plc
      • 2.1.1 Business Overview
        • 2.1.1.1 Allergan plc Description
        • 2.1.1.2 Allergan plc Headquarter, Main Business and Finance Overview
      • 2.1.2 Allergan plc Biosimilar Product Introduction
        • 2.1.2.1 Biosimilar Production Bases, Sales Regions and Major Competitors
        • 2.1.2.2 Biosimilar Product Information
      • 2.1.3 Allergan plc Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.1.3.1 Allergan plc Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.1.3.2 Global Allergan plc Biosimilar Market Share in 2017
    • 2.2 BIOCAD
      • 2.2.1 Business Overview
        • 2.2.1.1 BIOCAD Description
        • 2.2.1.2 BIOCAD Headquarter, Main Business and Finance Overview
      • 2.2.2 BIOCAD Biosimilar Product Introduction
        • 2.2.2.1 Biosimilar Production Bases, Sales Regions and Major Competitors
        • 2.2.2.2 Biosimilar Product Information
      • 2.2.3 BIOCAD Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.2.3.1 BIOCAD Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.2.3.2 Global BIOCAD Biosimilar Market Share in 2017
    • 2.3 Biocon
      • 2.3.1 Business Overview
        • 2.3.1.1 Biocon Description
        • 2.3.1.2 Biocon Headquarter, Main Business and Finance Overview
      • 2.3.2 Biocon Biosimilar Product Introduction
        • 2.3.2.1 Biosimilar Production Bases, Sales Regions and Major Competitors
        • 2.3.2.2 Biosimilar Product Information
      • 2.3.3 Biocon Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.3.3.1 Biocon Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.3.3.2 Global Biocon Biosimilar Market Share in 2017
    • 2.4 BioXpress Therapeutics SA
      • 2.4.1 Business Overview
        • 2.4.1.1 BioXpress Therapeutics SA Description
        • 2.4.1.2 BioXpress Therapeutics SA Headquarter, Main Business and Finance Overview
      • 2.4.2 BioXpress Therapeutics SA Biosimilar Product Introduction
        • 2.4.2.1 Biosimilar Production Bases, Sales Regions and Major Competitors
        • 2.4.2.2 Biosimilar Product Information
      • 2.4.3 BioXpress Therapeutics SA Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.4.3.1 BioXpress Therapeutics SA Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.4.3.2 Global BioXpress Therapeutics SA Biosimilar Market Share in 2017
    • 2.5 Boehringer Ingelheim GmbH
      • 2.5.1 Business Overview
        • 2.5.1.1 Boehringer Ingelheim GmbH Description
        • 2.5.1.2 Boehringer Ingelheim GmbH Headquarter, Main Business and Finance Overview
      • 2.5.2 Boehringer Ingelheim GmbH Biosimilar Product Introduction
        • 2.5.2.1 Biosimilar Production Bases, Sales Regions and Major Competitors
        • 2.5.2.2 Biosimilar Product Information
      • 2.5.3 Boehringer Ingelheim GmbH Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.5.3.1 Boehringer Ingelheim GmbH Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.5.3.2 Global Boehringer Ingelheim GmbH Biosimilar Market Share in 2017
    • 2.6 Celltrion Inc.
      • 2.6.1 Business Overview
        • 2.6.1.1 Celltrion Inc. Description
        • 2.6.1.2 Celltrion Inc. Headquarter, Main Business and Finance Overview
      • 2.6.2 Celltrion Inc. Biosimilar Product Introduction
        • 2.6.2.1 Biosimilar Production Bases, Sales Regions and Major Competitors
        • 2.6.2.2 Biosimilar Product Information
      • 2.6.3 Celltrion Inc. Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.6.3.1 Celltrion Inc. Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.6.3.2 Global Celltrion Inc. Biosimilar Market Share in 2017
    • 2.7 Coherus BioSciences, Inc
      • 2.7.1 Business Overview
        • 2.7.1.1 Coherus BioSciences, Inc Description
        • 2.7.1.2 Coherus BioSciences, Inc Headquarter, Main Business and Finance Overview
      • 2.7.2 Coherus BioSciences, Inc Biosimilar Product Introduction
        • 2.7.2.1 Biosimilar Production Bases, Sales Regions and Major Competitors
        • 2.7.2.2 Biosimilar Product Information
      • 2.7.3 Coherus BioSciences, Inc Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.7.3.1 Coherus BioSciences, Inc Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.7.3.2 Global Coherus BioSciences, Inc Biosimilar Market Share in 2017
    • 2.8 Dr. Reddy’s Laboratories Ltd.
      • 2.8.1 Business Overview
        • 2.8.1.1 Dr. Reddy’s Laboratories Ltd. Description
        • 2.8.1.2 Dr. Reddy’s Laboratories Ltd. Headquarter, Main Business and Finance Overview
      • 2.8.2 Dr. Reddy’s Laboratories Ltd. Biosimilar Product Introduction
        • 2.8.2.1 Biosimilar Production Bases, Sales Regions and Major Competitors
        • 2.8.2.2 Biosimilar Product Information
      • 2.8.3 Dr. Reddy’s Laboratories Ltd. Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.8.3.1 Dr. Reddy’s Laboratories Ltd. Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.8.3.2 Global Dr. Reddy’s Laboratories Ltd. Biosimilar Market Share in 2017
    • 2.9 Genor BioPharma Co. Ltd
      • 2.9.1 Business Overview
        • 2.9.1.1 Genor BioPharma Co. Ltd Description
        • 2.9.1.2 Genor BioPharma Co. Ltd Headquarter, Main Business and Finance Overview
      • 2.9.2 Genor BioPharma Co. Ltd Biosimilar Product Introduction
        • 2.9.2.1 Biosimilar Production Bases, Sales Regions and Major Competitors
        • 2.9.2.2 Biosimilar Product Information
      • 2.9.3 Genor BioPharma Co. Ltd Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.9.3.1 Genor BioPharma Co. Ltd Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.9.3.2 Global Genor BioPharma Co. Ltd Biosimilar Market Share in 2017
    • 2.10 Intas Pharmaceuticals Limited
      • 2.10.1 Business Overview
        • 2.10.1.1 Intas Pharmaceuticals Limited Description
        • 2.10.1.2 Intas Pharmaceuticals Limited Headquarter, Main Business and Finance Overview
      • 2.10.2 Intas Pharmaceuticals Limited Biosimilar Product Introduction
        • 2.10.2.1 Biosimilar Production Bases, Sales Regions and Major Competitors
        • 2.10.2.2 Biosimilar Product Information
      • 2.10.3 Intas Pharmaceuticals Limited Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.10.3.1 Intas Pharmaceuticals Limited Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.10.3.2 Global Intas Pharmaceuticals Limited Biosimilar Market Share in 2017
    • 2.11 Novartis AG
      • 2.11.1 Business Overview
      • 2.11.2 Novartis AG Biosimilar Product Introduction
      • 2.11.3 Novartis AG Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.12 Pfizer, Inc.
      • 2.12.1 Business Overview
      • 2.12.2 Pfizer, Inc. Biosimilar Product Introduction
      • 2.12.3 Pfizer, Inc. Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.13 Reliance Life Sciences
      • 2.13.1 Business Overview
      • 2.13.2 Reliance Life Sciences Biosimilar Product Introduction
      • 2.13.3 Reliance Life Sciences Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    3 Global Biosimilar Market Competition, by Manufacturer

    • 3.1 Global Biosimilar Sales and Market Share by Manufacturer (2016-2017)
    • 3.2 Global Biosimilar Revenue and Market Share by Manufacturer (2016-2017)
    • 3.3 Global Biosimilar Price by Manufacturer (2016-2017)
    • 3.4 Market Concentration Rate
      • 3.4.1 Top 3 Biosimilar Manufacturer Market Share in 2017
      • 3.4.2 Top 5 Biosimilar Manufacturer Market Share in 2017
    • 3.5 Market Competition Trend

    4 Global Biosimilar Market Analysis by Regions

    • 4.1 Global Biosimilar Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Biosimilar Sales by Regions (2013-2018)
      • 4.1.2 Global Biosimilar Revenue by Regions (2013-2018)
    • 4.2 North America Biosimilar Sales, Revenue and Growth Rate (2013-2018)
    • 4.3 Europe Biosimilar Sales, Revenue and Growth Rate (2013-2018)
    • 4.4 Asia-Pacific Biosimilar Sales, Revenue and Growth Rate (2013-2018)
    • 4.5 South America Biosimilar Sales, Revenue and Growth Rate (2013-2018)
    • 4.6 Middle East and Africa Biosimilar Sales, Revenue and Growth Rate (2013-2018)

    5 North America Biosimilar by Countries, Type, Application and Manufacturers

    • 5.1 North America Biosimilar Sales, Revenue and Market Share by Countries
      • 5.1.1 North America Biosimilar Sales by Countries (2013-2018)
      • 5.1.2 North America Biosimilar Revenue by Countries (2013-2018)
      • 5.1.3 United States Biosimilar Sales and Growth Rate (2013-2018)
      • 5.1.4 Canada Biosimilar Sales and Growth Rate (2013-2018)
      • 5.1.5 Mexico Biosimilar Sales and Growth Rate (2013-2018)
    • 5.2 North America Biosimilar Sales and Revenue (Value) by Manufacturers (2016-2017)
      • 5.2.1 North America Biosimilar Sales by Manufacturers (2016-2017)
      • 5.2.2 North America Biosimilar Revenue by Manufacturers (2016-2017)
    • 5.3 North America Biosimilar Sales, Revenue and Market Share by Type (2013-2018)
      • 5.3.1 North America Biosimilar Sales and Sales Share by Type (2013-2018)
      • 5.3.2 North America Biosimilar Revenue and Revenue Share by Type (2013-2018)
    • 5.4 North America Biosimilar Sales, Revenue and Market Share by Application (2013-2018)
      • 5.4.1 North America Biosimilar Sales and Sales Share by Application (2013-2018)
      • 5.4.2 North America Biosimilar Revenue and Revenue Share by Application (2013-2018)

    6 Europe Biosimilar by Countries, Type, Application and Manufacturers

    • 6.1 Europe Biosimilar Sales, Revenue and Market Share by Countries
      • 6.1.1 Europe Biosimilar Sales by Countries (2013-2018)
      • 6.1.2 Europe Biosimilar Revenue by Countries (2013-2018)
      • 6.1.3 Germany Biosimilar Sales and Growth Rate (2013-2018)
      • 6.1.4 UK Biosimilar Sales and Growth Rate (2013-2018)
      • 6.1.5 France Biosimilar Sales and Growth Rate (2013-2018)
      • 6.1.6 Russia Biosimilar Sales and Growth Rate (2013-2018)
      • 6.1.7 Italy Biosimilar Sales and Growth Rate (2013-2018)
    • 6.2 Europe Biosimilar Sales and Revenue (Value) by Manufacturers (2016-2017)
      • 6.2.1 Europe Biosimilar Sales by Manufacturers (2016-2017)
      • 6.2.2 Europe Biosimilar Revenue by Manufacturers (2016-2017)
    • 6.3 Europe Biosimilar Sales, Revenue and Market Share by Type (2013-2018)
      • 6.3.1 Europe Biosimilar Sales and Sales Share by Type (2013-2018)
      • 6.3.2 Europe Biosimilar Revenue and Revenue Share by Type (2013-2018)
    • 6.4 Europe Biosimilar Sales, Revenue and Market Share by Application (2013-2018)
      • 6.4.1 Europe Biosimilar Sales and Sales Share by Application (2013-2018)
      • 6.4.2 Europe Biosimilar Revenue and Revenue Share by Application (2013-2018)

    7 Asia-Pacific Biosimilar by Countries, Type, Application and Manufacturers

    • 7.1 Asia-Pacific Biosimilar Sales, Revenue and Market Share by Countries
      • 7.1.1 Asia-Pacific Biosimilar Sales by Countries (2013-2018)
      • 7.1.2 Asia-Pacific Biosimilar Revenue by Countries (2013-2018)
      • 7.1.3 China Biosimilar Sales and Growth Rate (2013-2018)
      • 7.1.4 Japan Biosimilar Sales and Growth Rate (2013-2018)
      • 7.1.5 Korea Biosimilar Sales and Growth Rate (2013-2018)
      • 7.1.6 India Biosimilar Sales and Growth Rate (2013-2018)
      • 7.1.7 Southeast Asia Biosimilar Sales and Growth Rate (2013-2018)
    • 7.2 Asia-Pacific Biosimilar Sales and Revenue (Value) by Manufacturers (2016-2017)
      • 7.2.1 Asia-Pacific Biosimilar Sales by Manufacturers (2016-2017)
      • 7.2.2 Asia-Pacific Biosimilar Revenue by Manufacturers (2016-2017)
    • 7.3 Asia-Pacific Biosimilar Sales, Revenue and Market Share by Type (2013-2018)
      • 7.3.1 Asia-Pacific Biosimilar Sales and Sales Share by Type (2013-2018)
      • 7.3.2 Asia-Pacific Biosimilar Revenue and Revenue Share by Type (2013-2018)
    • 7.4 Asia-Pacific Biosimilar Sales, Revenue and Market Share by Application (2013-2018)
      • 7.4.1 Asia-Pacific Biosimilar Sales and Sales Share by Application (2013-2018)
      • 7.4.2 Asia-Pacific Biosimilar Revenue and Revenue Share by Application (2013-2018)

    8 South America Biosimilar by Countries, Type, Application and Manufacturers

    • 8.1 South America Biosimilar Sales, Revenue and Market Share by Countries
      • 8.1.1 South America Biosimilar Sales by Countries (2013-2018)
      • 8.1.2 South America Biosimilar Revenue by Countries (2013-2018)
      • 8.1.3 Brazil Biosimilar Sales and Growth Rate (2013-2018)
      • 8.1.4 Argentina Biosimilar Sales and Growth Rate (2013-2018)
      • 8.1.5 Colombia Biosimilar Sales and Growth Rate (2013-2018)
    • 8.2 South America Biosimilar Sales and Revenue (Value) by Manufacturers (2016-2017)
      • 8.2.1 South America Biosimilar Sales by Manufacturers (2016-2017)
      • 8.2.2 South America Biosimilar Revenue by Manufacturers (2016-2017)
    • 8.3 South America Biosimilar Sales, Revenue and Market Share by Type (2013-2018)
      • 8.3.1 South America Biosimilar Sales and Sales Share by Type (2013-2018)
      • 8.3.2 South America Biosimilar Revenue and Revenue Share by Type (2013-2018)
    • 8.4 South America Biosimilar Sales, Revenue and Market Share by Application (2013-2018)
      • 8.4.1 South America Biosimilar Sales and Sales Share by Application (2013-2018)
      • 8.4.2 South America Biosimilar Revenue and Revenue Share by Application (2013-2018)

    9 Middle East and Africa Biosimilar by Countries, Type, Application and Manufacturers

    • 9.1 Middle East and Africa Biosimilar Sales, Revenue and Market Share by Countries
      • 9.1.1 Middle East and Africa Biosimilar Sales by Countries (2013-2018)
      • 9.1.2 Middle East and Africa Biosimilar Revenue by Countries (2013-2018)
      • 9.1.3 Saudi Arabia Biosimilar Sales and Growth Rate (2013-2018)
      • 9.1.4 UAE Biosimilar Sales and Growth Rate (2013-2018)
      • 9.1.5 Egypt Biosimilar Sales and Growth Rate (2013-2018)
      • 9.1.6 Nigeria Biosimilar Sales and Growth Rate (2013-2018)
      • 9.1.7 South Africa Biosimilar Sales and Growth Rate (2013-2018)
    • 9.2 Middle East and Africa Biosimilar Sales and Revenue (Value) by Manufacturers (2016-2017)
      • 9.2.1 Middle East and Africa Biosimilar Sales by Manufacturers (2016-2017)
      • 9.2.2 Middle East and Africa Biosimilar Revenue by Manufacturers (2016-2017)
    • 9.3 Middle East and Africa Biosimilar Sales, Revenue and Market Share by Type (2013-2018)
      • 9.3.1 Middle East and Africa Biosimilar Sales and Sales Share by Type (2013-2018)
      • 9.3.1 Middle East and Africa Biosimilar Revenue and Revenue Share by Type (2013-2018)
    • 9.4 Middle East and Africa Biosimilar Sales, Revenue and Market Share by Application (2013-2018)
      • 9.4.1 Middle East and Africa Biosimilar Sales and Sales Share by Application (2013-2018)
      • 9.4.2 Middle East and Africa Biosimilar Revenue and Revenue Share by Application (2013-2018)

    10 Global Biosimilar Market Segment by Type

    • 10.1 Global Biosimilar Sales, Revenue and Market Share by Type (2013-2018)
      • 10.1.1 Global Biosimilar Sales and Market Share by Type (2013-2018)
      • 10.1.2 Global Biosimilar Revenue and Market Share by Type (2013-2018)
    • 10.2 Human Growth Hormones Sales Growth and Price
      • 10.2.1 Global Human Growth Hormones Sales Growth (2013-2018)
      • 10.2.2 Global Human Growth Hormones Price (2013-2018)
    • 10.3 Monoclonal Antibodies Sales Growth and Price
      • 10.3.1 Global Monoclonal Antibodies Sales Growth (2013-2018)
      • 10.3.2 Global Monoclonal Antibodies Price (2013-2018)
    • 10.4 Insulin Sales Growth and Price
      • 10.4.1 Global Insulin Sales Growth (2013-2018)
      • 10.4.2 Global Insulin Price (2013-2018)
    • 10.5 Peptides Sales Growth and Price
      • 10.5.1 Global Peptides Sales Growth (2013-2018)
      • 10.5.2 Global Peptides Price (2013-2018)
    • 10.6 Erythropoietin Sales Growth and Price
      • 10.6.1 Global Erythropoietin Sales Growth (2013-2018)
      • 10.6.2 Global Erythropoietin Price (2013-2018)
    • 10.7 Others Sales Growth and Price
      • 10.7.1 Global Others Sales Growth (2013-2018)
      • 10.7.2 Global Others Price (2013-2018)

    11 Global Biosimilar Market Segment by Application

    • 11.1 Global Biosimilar Sales Market Share by Application (2013-2018)
    • 11.2 Oncology Sales Growth (2013-2018)
    • 11.3 Chronic and Autoimmune Diseases Sales Growth (2013-2018)
    • 11.4 Growth Hormone Deficiency Sales Growth (2013-2018)
    • 11.5 Infectious Diseases Sales Growth (2013-2018)
    • 11.6 Others Sales Growth (2013-2018)

    12 Biosimilar Market Forecast (2018-2023)

    • 12.1 Global Biosimilar Sales, Revenue and Growth Rate (2018-2023)
    • 12.2 Biosimilar Market Forecast by Regions (2018-2023)
      • 12.2.1 North America Biosimilar Market Forecast (2018-2023)
      • 12.2.2 Europe Biosimilar Market Forecast (2018-2023)
      • 12.2.3 Asia-Pacific Biosimilar Market Forecast (2018-2023)
      • 12.2.4 South America Biosimilar Market Forecast (2018-2023)
      • 12.2.5 Middle East and Africa Biosimilar Market Forecast (2018-2023)
    • 12.3 Biosimilar Market Forecast by Type (2018-2023)
      • 12.3.1 Global Biosimilar Sales Forecast by Type (2018-2023)
      • 12.3.2 Global Biosimilar Market Share Forecast by Type (2018-2023)
    • 12.4 Biosimilar Market Forecast by Application (2018-2023)
      • 12.4.1 Global Biosimilar Sales Forecast by Application (2018-2023)
      • 12.4.2 Global Biosimilar Market Share Forecast by Application (2018-2023)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Biosimilar . Industry analysis & Market Report on Biosimilar is a syndicated market report, published as Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Biosimilar Market 2018, Forecast to 2023. It is complete Research Study and Industry Analysis of Biosimilar market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$4,880.00
      		$7,320.00
      		$9,760.00
      		3,899.12
      		5,848.68
      		7,798.24
      		4,567.68
      		6,851.52
      		9,135.36
      		768,014.40
      		1,152,021.60
      		1,536,028.80
      		407,431.20
      		611,146.80
      		814,862.40
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo